Time to stop mammography screening?

CMAJ. Canadian Medical Association Journal

Volumn 183, Issue 17, 2011, Pages 1957-1958

  Gøtzsche, Peter C ^a  

^a Nordic Cochrane Centre   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

TAMOXIFEN;

ADVANCED CANCER; AWARENESS; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER SCREENING; EVIDENCE BASED MEDICINE; GEOGRAPHIC DISTRIBUTION; HIGH RISK POPULATION; HUMAN; MAMMOGRAPHY; MEDICAL EXAMINATION; NOTE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; TUMOR VOLUME; WOMEN'S HEALTH;

EID: 81855173454     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.111721     Document Type: Note

References (11)

1. Canadian Task Force on Preventive Health Care. Recommendations on screening for breast cancer in average-risk women aged 40-74 years. CMAJ 2011;183:1991-2001.
2. Jørgensen KJ, Keen JD, Gøtzsche PC. Is mammographic screening justifiable considering its substantial overdiagnosis rate and minor effect on mortality? Radiology 2011;260:621-27.
3. Gøtzsche PC, Nielsen M. Screening for breast cancer with mammography [review]. Cochrane Database Syst Rev 2009; (1): CD001877.
4. Gøtzsche PC, Jørgensen KJ, Zahl PH, et al. Why mammography screening hasn't lived up to expectations from the randomised trials. Cancer Causes Control. In press.
5. Jørgensen KJ, Zahl PH, Gøtzsche PC. Breast cancer mortality in organised mammography screening in Denmark. A comparative study. BMJ 2010;340:c1241.
6. Autier P, Boniol M, LaVecchia C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database [published erratum appears in BMJ 2010;341:c4480. LaVecchia, Carlo [corrected to La Vecchia, Carlo]. BMJ 2010;341:c3620.
7. Autier P, Boniol M, Gavin A, et al. Breast cancer mortality in neighbouring European countries with different levels of screening but similar access to treatment: trend analysis of WHO mortality database. BMJ 2011;343:d4411.
8. Bleyer A. US breast cancer mortality is consistent with European data. BMJ 2011;343:d5630.
9. Nyström L, Rutqvist LE, Wall S, et al. Breast cancer screening with mammography: overview of Sweidish randomised trials. Lancet 1993;341:973-8. (Pubitemid 23109165)
10. Zahl PH, Gøtzsche PC, Mæhlen J. Natural history of breast cancers detected in the Swedish mammography screening program; a cohort study. Lancet Oncol 2011 Oct. 11 [Epub ahead of print].
11. Jørgensen KJ, Gøtzsche PC. Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends. BMJ 2009;339:b2587.